lyophilised powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved for therapeutic use | No marketing authorisation from major agencies |
| Legal classification | Varies by jurisdiction | Prescription-only or controlled in several countries |
| Common synonyms | Melanotan II; MT-II | Also referenced by catalogue codes |
| Typical analytical method | Reverse-phase HPLC | Often paired with mass spectrometry |
| Primary literature focus | Receptor pharmacology | Pigmentation and melanocortin signalling |
Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
April 8: Decree protecting wives of political emigrants, but not husbands of female emigrants. August 31: Decree adjusting penalties for pregnant women sentenced to the pillory. September 20: Law on civil status registration and divorce, establishing near equality between spouses. Minimum marriage age set at 13 for girls and 15 for boys. 1793
In January 2023, Vice President Geraldo Alckmin met with Vice President Frans Timmermans of the EU Commission in Brasília. During his visit to Brazil, Timmermans said that President Lula's efforts to end destruction in the Amazon deserves support and cooperation from the European Union, adding that the EU could donate up to €750,000 to help the Yanomami people facing a humanitarian crisis. In March 2023, the EU's commissioner for competition Margrethe Vestager met with Vice President Alckmin and other Brazilian officials during a meeting in Brasília to unveil the EU-Brazil bilateral Investment Map. In June 2023, Lula met with EU president Ursula von der Leyen to discuss areas such as environment, science and technology and trade, namely the EU-Mercosur trade deal. Lula expressed concerns over a European Union's side letter proposal of sanctioning Mercosur goods in case they fail to meet environmental goals saying that "between partners there should be mutual confidence not mistrust and sanctions" and that the sanctions could hurt genuine Brazilian green efforts. During the meeting the European Union pledged to donate 20 million euros to the Amazon Fund. In July 2023, numerous Latin American, Caribbean and European leaders, including Lula, attended the III EU-CELAC summit in Brussels to discuss topics such as global hunger, inequalities, poverty and climate change. On the sidelines of the summit, Lula made the case for the EU-Mercosur trade deal and expressed concern for protectionist policies in the agreement.
The earlier DOx drugs like DOM and DOET were subsequently followed by DOB, which was developed by Shulgin and colleagues like Claudio Naranjo, in 1971, and by DOI, DOC, and a few other analogues, which were developed by another research group, in 1973. After this, numerous other DOx drugs were synthesized and characterized, both by Shulgin and other scientists. Following its discovery, DOI has become widely used in scientific research in the study of the serotonin 5-HT2 receptors.
Sources: en.wikipedia.org
The plutonium present in spent nuclear fuel contains about 12% of 241Pu. Because it converts to 241Am, 241Pu can be extracted and may be used to generate further (isotopically pure) 241Am. However, this process is rather slow: half of the original amount of 241Pu decays to 241Am after about 14 years, and the 241Am amount reaches a maximum after 70 years. The obtained 241Am can be used for generating heavier americium isotopes by further neutron capture inside a nuclear reactor. In a light water reactor (LWR), 79% of neutron captures on 241Am convert to 242Am and 10% to its nuclear isomer 242mAm:
== Interactions == No clinically relevant interactions have been found in studies with a number of drugs that are known for their interaction potential (simvastatin, warfarin, digoxin, and oral contraceptives). Nonetheless, since albiglutide slows gastric emptying, it could conceivably increase absorption of other drugs if taken at the same time.
=== Future === Improving public information about use of dietary supplements involves investments in professional training programs, further studies of population and nutrient needs, expanding the database information, enhancing collaborations between governments and universities, and translating dietary supplement research into useful information for consumers, health professionals, scientists, and policymakers. Future demonstration of efficacy from use of dietary supplements requires high-quality clinical research using rigorously qualified products and compliance with established guidelines for reporting of clinical trial results (e.g., CONSORT guidelines).
== Occurrence == Potassium is formed in supernovae by nucleosynthesis from lighter atoms. Potassium is believed to be created in Type II supernovae via an oxygen-consuming nuclear reaction, probably during the explosive stage of the nova. 40K is also formed in s-process nucleosynthesis and the neon burning process. Potassium is the 20th most abundant element in the Solar System and the 17th most abundant element by weight in the Earth. It makes up about 2.6% of the weight of the Earth's crust and is the seventh most abundant element in the crust. The potassium concentration in seawater is 0.39 g/L (0.039 wt/v%), about one twenty-seventh the concentration of sodium.
Sources: en.wikipedia.org
Gastroptosis is the abnormal downward dislocation (ptosis) of the stomach in which its greater curve is displaced below the iliac crest. The stomach is often elongated. The condition frequently causes digestive symptoms, epigastric pain, constipation, gastric reflux, nausea, decreased appetite, gastroparesis (delayed gastric emptying), and in severe cases Median arcuate ligament syndrome. It is much more prominent in women than men, and is diagnosed with x-ray using barium contrast. Gastroptosis is mainly caused by the relaxation of surrounding ligaments and mesenteries as a result of the weight of the stomach and may be due to genetic connective tissue disease.
Real advancement came in the early 1800s, when Linnaeus's student Erik Acharius—later hailed as the "father of lichenology"—re-examined the group. From 1798 to 1814, Acharius published four influential monographs that divided Lichen into numerous genera and sketched a finer hierarchy: Lichenographiae Suecicae Prodromus (1798), Methodus (1803), Lichenographia Universalis (1810), and Synopsis Methodica Lichenum (1814). Beyond cataloguing hundreds of species, he introduced microscopic characters—such as the structure of the spore-producing bodies (apothecia)—as classificatory tools. His anatomical focus freed lichenology from its old dependence on thallus form (crustose, foliose, fruticose) and laid the groundwork for a multi-character "natural" system. During the early–mid 1800s, lichen taxonomists steadily wove fresh microscopic insights into their work. With compound microscopes common by the 1830s, researchers saw that lichens contain distinct internal layers and reproductive organs. A cadre of European "microscope taxonomists"—Antoine Fée, Giuseppe De Notaris, Vittore Trevisan, Camille Montagne, Ernst Stizenberger and Edward Tuckerman—used those details to delimit genera on ascospore shape, septation and exciple anatomy, giving lichenology its first genuinely anatomical classification. Meanwhile, William Nylander drew on micro‑anatomy to craft a far richer hierarchical scheme, describing hundreds of new taxa yet largely ignoring spore data.
Argon is used to displace oxygen- and moisture-containing air in packaging material to extend the shelf-lives of the contents (argon has the European food additive code E938). Aerial oxidation, hydrolysis, and other chemical reactions that degrade the products are retarded or prevented entirely. High-purity chemicals and pharmaceuticals are sometimes packed and sealed in argon. In winemaking, argon is used in a variety of activities to provide a barrier against oxygen at the liquid surface, which can spoil wine by fueling both microbial metabolism (as with acetic acid bacteria) and standard redox chemistry. Argon is sometimes used as the propellant in aerosol cans. Argon is also used as a preservative for such products as varnish, polyurethane, and paint, by displacing air to prepare a container for storage. Since 2002, the American National Archives stores important national documents such as the Declaration of Independence and the Constitution within argon-filled cases to inhibit their degradation. Argon is preferable to the helium that had been used in the preceding five decades, because helium gas escapes through the intermolecular pores in most containers and must be regularly replaced.
Sources: en.wikipedia.org
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.
Much of the evidence comes from case reports and accounts of unregulated use rather than controlled trials. Differences in product purity and dosing add further variability.
Laboratory work focuses on receptor binding and cellular signalling. Observational reports document outcomes after use, and analytical chemists examine samples to assess content and purity.
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.